t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Blood

Volumn 120, Issue 19, 2012, Pages 3949-3957

  Ansell, Stephen M ^a   Akasaka, Takashi ^b   McPhail, Ellen ^a   Manske, Michelle ^a   Braggio, Esteban ^c   Price Troska, Tammy ^a   Ziesmer, Steven ^a   Secreto, Frank ^a   Fonseca, Rafael ^c   Gupta, Mamta ^a   Law, Mark ^a   Witzig, Thomas E ^a   Dyer, Martin J S ^b   Dogan, Ahmet ^a   Cerhan, James R ^a   Novak, Anne J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GPR 34 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION X; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 84868602456     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-389908     Document Type: Article

References (41)

1. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96(3):808-822. (Pubitemid 30618048)
2. Ott G, Katzenberger T, Greiner A, et al. The t(11; 18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997;57(18):3944-3948. (Pubitemid 27427681)
3. Auer IA, Gascoyne RD, Connors JM, et al. t(11; 18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol. 1997;8(10):979-985. (Pubitemid 27475729)
4. Levine EG, Arthur DC, Machnicki J, et al. Four new recurring translocations in non-Hodgkin lymphoma. Blood. 1989;74(5):1796-1800. (Pubitemid 19251562)
5. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96(1):35-45. (Pubitemid 29044151)
6. Streubel B, Lamprecht A, Dierlamm J, et al. T(14; 18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood. 2003;101(6):2335-2339. (Pubitemid 36302078)
7. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19(4): 652-658. (Pubitemid 40521171)
8. Baens M, Finalet Ferreiro J, Tousseyn T, et al. t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34. Haematologica. 2012;97(2):184-188.
9. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer. 2004; 4(8):644-653. (Pubitemid 39025059)
10. Ruland J, Duncan GS, Elia A, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell. 2001;104(1):33-42. (Pubitemid 32144970)
11. Xue L, Morris SW, Orihuela C, et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat Immunol. 2003;4(9):857-865. (Pubitemid 37098656)
12. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem. 2001;276(22):19012-19019.
13. Sonoki T, Willis TG, Oscier DG, Karran EL, Siebert R, Dyer MJ. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR. Leukemia. 2004;18(12):2026-2031. (Pubitemid 40028430)
14. Akasaka T, Balasas T, Russell LJ, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007;109(8):3451-3461. (Pubitemid 46572535)
15. Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol. 2006;30(12): 1546-1553. (Pubitemid 44815508)
16. Braggio E, Keats JJ, Leleu X, et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res. 2009; 69(8):3579-3588.
17. Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z. Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol. 2006;13(2):215-228.
18. Chng WJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosaassociated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood. 2009;113(3):635- 645.
19. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008;105(36):13520-13525.
20. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serumcultured cell lines. Cancer Cell. 2006;9(5):391-403. (Pubitemid 43668737)
21. Suryani S, Fulcher DA, Santner-Nanan B, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 2010;115(3): 519-529.
22. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
23. Engemaier E, Rompler H, Schoneberg T, Schulz A. Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34. Genomics. 2006;87(2):254-264. (Pubitemid 43117446)
24. Schoneberg T, Schulz A, Grosse R, et al. A novel subgroup of class I G-protein-coupled receptors. Biochim Biophys Acta. 1999;1446(1-2):57-70. (Pubitemid 29299324)
25. Sugo T, Tachimoto H, Chikatsu T, et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun. 2006; 341(4):1078-1087. (Pubitemid 43221776)
26. Schulz A, Schoneberg T. The structural evolution of a P2Y-like G-protein-coupled receptor. J Biol Chem. 2003;278(37):35531-35541. (Pubitemid 37102325)
27. Zhu SZ, Wang SZ, Hu J, el-Fakahany EE. An arginine residue conserved in most G proteincoupled receptors is essential for the function of the m1 muscarinic receptor. Mol Pharmacol. 1994;45(3):517-523. (Pubitemid 24094942)
28. Palanisamy N, Ateeq B, Kalyana-Sundaram S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med. 2010;16(7):793-798.
29. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79-94. (Pubitemid 46164746)
30. Foord SM. Receptor classification: post genome. Curr Opin Pharmacol. 2002;2(5):561-566.
31. Pierce KL, Premont RT, Lefkowitz RJ. Seventransmembrane receptors. Nat Rev Mol Cell Biol. 2002;3(9):639-650.
32. Lee DK, Nguyen T, Lynch KR, et al. Discovery and mapping of ten novel G protein-coupled receptor genes. Gene. 2001;275(1):83-91. (Pubitemid 32907329)
33. Marchese A, Sawzdargo M, Nguyen T, et al. Discovery of three novel orphan G-protein-coupled receptors. Genomics. 1999;56(1):12-21. (Pubitemid 29107199)
34. Liebscher I, Muller U, Teupser D, et al. Altered immune response in mice deficient for the G protein-coupled receptor GPR34. J Biol Chem. 2010.
35. Levoye A, Dam J, Ayoub MA, Guillaume JL, Jockers R. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep. 2006;7(11):1094-1098. (Pubitemid 44660563)
36. Thangaraju M, Cresci GA, Liu K, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009; 69(7):2826-2832.
37. Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 2006; 17(6):501-519. (Pubitemid 44793122)
38. McAllister-Lucas LM, Ruland J, Siu K, et al. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci U S A. 2007;104(1):139-144. (Pubitemid 46067998)
39. Vegliante MC, Royo C, Palomero J, et al. Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. PLoS One. 2011;6(6): e21382.
40. Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008;111(2):800-805.
41. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94(11):1555-1562.